Eradication of Hp has also been shown to decrease gastric cancer incidence, so clinical guidelines recommend testing for and treating infection in patients with identified gastric lesions (e.g., gastritis, atrophy, metaplasia, dysplasia) followed by confirmation of eradication testing (Lee et al., 2016; Gupta et al., 2020). Here, HP is linked to gastritis.